Great Ape Microbiomes

Chimpanzees, bonobos, and gorillas harbor more microbial diversity in their guts than do humans, a study shows.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA COMMONS, IKIWANERCompared with those of humans, the gut microbiomes of chimpanzees, bonobos, and gorillas are remarkably similar—owing in part to shared ancestral microbial diversity. Since diverging from Pan, “humanity has experienced a depletion of the gut flora,” a team led by investigators at the University of Texas in Austin reported in PNAS this week (November 3). Biologist Howard Ochman and his colleagues characterized the microbiomes of African apes, finding that chimpanzees, bonobos, and gorillas harbor more diverse species of bacteria than humans. “Compositional change in the microbiome was slow and clock-like during African ape diversification, but human microbiomes have deviated from the ancestral state at an accelerated rate,” they wrote in the paper.

“Ochman and colleagues show that human evolution was accompanied by both a rapid divergence of the microbiome from the microbiome of apes, and a drastic loss of diversity of the microbial community,” Thomas Bosch of Christian Albrechts University in Kiel, Germany, who was not involved in the work told New Scientist.

This loss of microbiome diversity had a lot to do with the human preference for animal-based diets, according to the team. But exactly how dietary and other factors may have altered the human gut has yet to be determined.

“Whether this change of the [microbiome] was one of the key drivers of human evolution and the development of human specific features remains to be shown,” Bosch told New Scientist.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies